Literature DB >> 7698256

A critical appraisal of synchronization methods applied to achieve maximal enrichment of HeLa cells in specific cell cycle phases.

M Knehr1, M Poppe, M Enulescu, W Eickelbaum, M Stoehr, D Schroeter, N Paweletz.   

Abstract

Synchronization of mammalian cell cultures is a prerequisite for studies of molecular mechanisms of cell cycle control. Many researchers routinely use widely spread tumor cell lines like HeLa for these purposes, and a great variety of synchronization protocols has been described. Generally, they have been developed for monolayer cultures, usually with satisfactory results. However, we found that is not necessarily the case for cells cultivated in suspension. A critical appraisal of different standardized methods for selective enrichment of HeLa cells in suspension in all phases of the cell cycle has been undertaken. Our results reveal that only a few of the applied procedures can really yield high numbers of synchronized cells in G1, S, G2, and M phases, working with suspension cultures.

Entities:  

Mesh:

Year:  1995        PMID: 7698256     DOI: 10.1006/excr.1995.1121

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  22 in total

1.  Mitotic phosphorylation prevents the binding of HMGN proteins to chromatin.

Authors:  M Prymakowska-Bosak; T Misteli; J E Herrera; H Shirakawa; Y Birger; S Garfield; M Bustin
Journal:  Mol Cell Biol       Date:  2001-08       Impact factor: 4.272

2.  Middle-Down and Chemical Proteomic Approaches to Reveal Histone H4 Modification Dynamics in Cell Cycle: Label-Free Semi-Quantification of Histone Tail Peptide Modifications Including Phosphorylation and Highly Sensitive Capture of Histone PTM Binding Proteins Using Photo-Reactive Crosslinkers.

Authors:  Kazuki Yamamoto; Yoko Chikaoka; Gosuke Hayashi; Ryosuke Sakamoto; Ryuji Yamamoto; Akira Sugiyama; Tatsuhiko Kodama; Akimitsu Okamoto; Takeshi Kawamura
Journal:  Mass Spectrom (Tokyo)       Date:  2015-07-14

3.  Certain and progressive methylation of histone H4 at lysine 20 during the cell cycle.

Authors:  James J Pesavento; Hongbo Yang; Neil L Kelleher; Craig A Mizzen
Journal:  Mol Cell Biol       Date:  2007-10-29       Impact factor: 4.272

4.  Cell sorting but not serum starvation is effective for SV40 human corneal epithelial cell cycle synchronization.

Authors:  Sara J Liliensiek; Kathleen Schell; Elise Howard; Paul Nealey; Christopher J Murphy
Journal:  Exp Eye Res       Date:  2006-03-20       Impact factor: 3.467

5.  Cell cycle-dependent binding of HMGN proteins to chromatin.

Authors:  Srujana Cherukuri; Robert Hock; Tetsuya Ueda; Frédéric Catez; Mark Rochman; Michael Bustin
Journal:  Mol Biol Cell       Date:  2008-02-20       Impact factor: 4.138

6.  Technology for cell cycle research with unstressed steady-state cultures.

Authors:  Valerie S Lebleu; Maureen Thornton; Steven R Gonda; Charles E Helmstetter
Journal:  Cytotechnology       Date:  2006-11-21       Impact factor: 2.058

7.  Combinatorial modification of human histone H4 quantitated by two-dimensional liquid chromatography coupled with top down mass spectrometry.

Authors:  James J Pesavento; Courtney R Bullock; Richard D LeDuc; Craig A Mizzen; Neil L Kelleher
Journal:  J Biol Chem       Date:  2008-04-01       Impact factor: 5.157

8.  The Golgi and endoplasmic reticulum remain independent during mitosis in HeLa cells.

Authors:  S A Jesch; A D Linstedt
Journal:  Mol Biol Cell       Date:  1998-03       Impact factor: 4.138

9.  Studying Cell Cycle-regulated Gene Expression by Two Complementary Cell Synchronization Protocols.

Authors:  Aintzane Apraiz; Jone Mitxelena; Ana Zubiaga
Journal:  J Vis Exp       Date:  2017-06-06       Impact factor: 1.355

10.  Cellular expression of human centromere protein C demonstrates a cyclic behavior with highest abundance in the G1 phase.

Authors:  M Knehr; M Poppe; D Schroeter; W Eickelbaum; E M Finze; U L Kiesewetter; M Enulescu; M Arand; N Paweletz
Journal:  Proc Natl Acad Sci U S A       Date:  1996-09-17       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.